This confirms a previous study where they correlated GVHD to a decrease of an IL-17 producing CD161+ CCR6+ T-cell subset, which most likely comprises both Th17-cells (CD4+) and MAIT-cells (CD4−) (56). The gene discussed is CD4; the disease is graft versus host disease.